118 related articles for article (PubMed ID: 11168657)
1. Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis.
Tabata H; Hara N; Otsuka S; Yamakage A; Yamazaki S; Koibuchi N
Int J Dermatol; 2000 Dec; 39(12):899-902. PubMed ID: 11168657
[TBL] [Abstract][Full Text] [Related]
2. A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.
Saigusa R; Yamashita T; Miura S; Hirabayashi M; Nakamura K; Miyagawa T; Fukui Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2019 May; 28(5):536-542. PubMed ID: 30739341
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous localization of endothelin-1 in patients with systemic sclerosis: immunoelectron microscopic study.
Tabata H; Yamakage A; Yamazaki S
Int J Dermatol; 1997 Apr; 36(4):272-5. PubMed ID: 9169324
[TBL] [Abstract][Full Text] [Related]
5. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
[TBL] [Abstract][Full Text] [Related]
6. Increased pigmentation in scleroderma.
Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes.
Henrot P; Pain C; Taïeb A; Truchetet ME; Cario M
Pigment Cell Melanoma Res; 2020 Nov; 33(6):895-898. PubMed ID: 32633087
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of alpha 1(I) and alpha 1(III) procollagen mRNA expression in systemic sclerosis skin tissue--an in situ hybridization study.
Ohtsuka T; Koibuchi N; Sakai H; Yamakage A; Yamazaki S
Arch Dermatol Res; 1999 Nov; 291(11):575-82. PubMed ID: 10638330
[TBL] [Abstract][Full Text] [Related]
9. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
[TBL] [Abstract][Full Text] [Related]
10. Guanine Deaminase in Human Epidermal Keratinocytes Contributes to Skin Pigmentation.
Jung JM; Noh TK; Jo SY; Kim SY; Song Y; Kim YH; Chang SE
Molecules; 2020 Jun; 25(11):. PubMed ID: 32517074
[TBL] [Abstract][Full Text] [Related]
11. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Russo B; Borowczyk J; Cacialli P; Moguelet P; Truchetet ME; Modarressi A; Brembilla NC; Bertrand J; Boehncke WH; Chizzolini C
Rheumatology (Oxford); 2022 Nov; 61(11):4558-4569. PubMed ID: 35171244
[TBL] [Abstract][Full Text] [Related]
12. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
13. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
[TBL] [Abstract][Full Text] [Related]
16. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
[TBL] [Abstract][Full Text] [Related]
17. Antigen specificity of antihistone antibodies in systemic sclerosis.
Hasegawa M; Sato S; Kikuchi K; Takehara K
Ann Rheum Dis; 1998 Aug; 57(8):470-5. PubMed ID: 9797552
[TBL] [Abstract][Full Text] [Related]
18. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
[TBL] [Abstract][Full Text] [Related]
19. Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
Leroy V; Henrot P; Barnetche T; Cario M; Darrigade AS; Manicki P; Doutre MS; Lazaro E; Constans J; Barcat D; Vernhes JP; Richez C; Taieb A; Truchetet ME; Seneschal J;
J Am Acad Dermatol; 2019 Feb; 80(2):478-484. PubMed ID: 30092330
[TBL] [Abstract][Full Text] [Related]
20. Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran R; Azam A; Black C; Dashwood MR
J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
